Indonesia vs Sur: Cases started on MDR-TB treatment
Indonesia
9,421
in 2024
Sur
10
in 2024
Indonesia rank
4th
Sur rank
1st
Cases started on MDR-TB treatment over time
- Indonesia
- Sur
How they compare
Indonesia currently reports 9,421 against 10 in Sur, a difference of 9,411.
That makes Indonesia's figure about 942.1 times Sur's.
Across all 15 years both countries report, Indonesia has been ahead every year.
Indonesia ranks 4th and Sur ranks 1st of 191 countries.
Indonesia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Indonesia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20 | 1 | 19 | Indonesia |
| 2010s | 2,125 | 0 | 2,125 | Indonesia |
| 2020s | 7,542 | 3.8 | 7,538 | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Indonesia or Sur?
- Indonesia, at 9,421 against 10 in Sur as of 2024.
- What is the difference in cases started on mdr-tb treatment between Indonesia and Sur?
- 9,411, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Sur?
- 15 years are reported by both, from 2009 to 2024.
- How do Indonesia and Sur rank globally for cases started on mdr-tb treatment?
- Indonesia ranks 4th and Sur ranks 1st of 191 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.